In my first CrossFit experience three years ago, I almost made myself puke because I wanted so badly to finish with a good time. Last year, I did another CrossFit workout that I hadn’t properly prepared for and cranked out 100 pull ups quickly…and I ended up walking around with T-rex arms for a WEEK because I physically could not straighten them. Not kidding.
“The Whole30: The 30-day Guide to Total Health and Food Freedom” contains more than enough recipes to get you through a month of breakfasts, lunches, dinners and even holidays and dinner parties. Plenty of recipes – think prosciutto-wrapped frittata muffins and Greek meatballs with avocado tzatziki sauce – can be found online too. Just search the hashtag “#Whole30” on social media sites such as Twitter and Instagram.
My husband and I are about to take a journey on the whole 30 and I was delighted when I came across your website. I have a couple of wonderings: Does all of your recipes strictly follow the whole 30 guidelines? I saw Coconut milk and honey in your chicken curry recipe…I really want to be able to use your recipes and follow the whole 30 the right way.
Prior to starting, athletes should state their name, and show and state the weights and equipment to be used. All video submissions must be uncut and unedited in order to accurately display the performance. A clock or timer, with the running workout time clearly visible should be in the frame throughout the entire workout. Shoot the video from an angle so ALL exercises can be clearly seen meeting the movement standards. Videos shot with a fisheye lens or similar lens may be rejected due to the visual distortion these lenses cause. If an athlete needs someone to adjust their camera during the WOD to capture all movements, this is acceptable, as long as the flow of the workout and the athlete is in view the whole time. It is the athletes responsibility to ensure their video meets the standard.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”